Drug Trial Radar · NCT07223229
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
45
Planned (sponsor's estimate)
Start
Dec 30, 2025
Primary completion
Dec 31, 2026
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Elixiron Immunotherapeutics (Hong Kong) Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 31, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to evaluate whether the drug EI-001 can help improve vitiligo symptoms. EI-001 is a novel antibody drug that affects the immune system to decrease uncontrolled inflammation. EI-001 has been investigated in human cell cultures, animal studies, and in a Phase 1 healthy volunteer study. The results so far show that EI-001 is a tolerable and potential new treatment for immune diseases such as vitiligo.
Conditions
- Non-segmental Vitiligo
Interventions
EI-001Biological
EI-001 drug product is supplied as a colorless to slightly yellow and sterile solution for infusion with a protein concentration of 10.0 mg/mL
PlaceboOther
0.9% sterile sodium chloride solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in F-VASI from baselineTime frame: Week 24
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
Marvel Clinical Research
Huntington Beach, California · Recruiting
Skin Care Research, LLC
Hollywood, Florida · Recruiting
U Mass Chan Medical School
Worcester, Massachusetts · Withdrawn
Apex Clinical Research Center (Lorain)
Lorain, Ohio · Recruiting
Apex Clinical Research Center, LLC (Mayfield)
Mayfield Heights, Ohio · Recruiting
Center for Clinical Studies
Houston, Texas · Recruiting
Linkou Chang Gung Memorial Hospital
Taoyuan, Taiwan · Recruiting
Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Niao-Sung, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.